Companies/US/CAH

CARDINAL HEALTH, INC.

Income flow

Annual
CAH 10-K Income StatementPeriod 2026-06-30Source 10-K
Pharmaceutical And Specialty Solutions$235BGmpd$13BAll Other$7BRevenue$254B+14% Y/YGross profit$10B+20% Y/YCost of revenue$244BOperating profit$3B+15% Y/YOperating expenses$7BNet profit$2B+10% Y/YTax$469MSG&A$6BR&D & other$1B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2026-06-30 · 10-K · USD
By activity
By activity$254.3B
  • Pharmaceutical And Specialty Solutions$234.8B92.3%
  • Gmpd$12.7B5.0%
  • All Other$6.8B2.7%
By geography
By geography$254.3B
  • United States$252.6B99.3%
  • Non-US$1.7B0.7%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.86%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.1.69%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).2.048PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.28.3%Shares outTotal shares currently outstanding (issued and not retired).231.6MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).232.0M
Upcoming dividend
Ex-dividend
2026-10-01
Next pay
2026-10-15
Last cash
0.516 · 2026-10-01
Stock splits
  1. 3:22001-04-23

Valuation

Trailing PE 32.7 (2026-06-30)PE trend

Fiscal PE5

PeriodEPSClosePE
2026-06-307.23236.4932.7
2025-06-306.45165.3825.6
2024-06-303.4595.0927.6
2023-06-30190.0890.1
2021-06-302.0851.0824.6

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.